Evidence map›Paper›PMID 14983013›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2004

The Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosis.

Jingyung Hur, Jessica Chesnes, Kathryn R Coser, Roseanna S Lee, Peter Geck, Kurt J Isselbacher, Toshi Shioda

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 78 citations in OpenAlex.

  1. A new era in cancer therapy: targeting the Proteasome-Bcl-2 axis.Journal of experimental & clinical cancer research : CR · 2025
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jingyung HurDepartment of Tumor Biology, Massachusetts General Hospital Cancer Center, Charlestown, MA 02129, USA.
Jessica Chesnes
Kathryn R Coser
Roseanna S Lee
Peter Geck
Kurt J Isselbacher
Toshi Shioda
Massachusetts General Hospital · USTufts University · US

Funding

FUNCTIONS OF MSG1 FAMILY TRANSCRIPTION ACTIVATORSR01CA082230 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI SHIODA, TOSHIHIRO · 1999 to 2005
$1.9M
NCI NIH HHS R01 CA082230NCI NIH HHS R01 CA82230
6 · The paper itself

Abstract

Evidence has been accumulating that some estrogen-dependent human breast cancers require estrogen for not only proliferation but also survival. To obtain insights into the molecular mechanisms of apoptosis of breast cancer cells subjected to estrogen starvation or exposed to antiestrogens, we characterized changes in the gene expression profile of MCF-7/BUS human breast cancer cells and revealed a strong induction of Bik, a member of the BH3-only proapoptotic proteins. The Bik mRNA transcript and protein were strongly induced by estrogen starvation or exposure to fulvestrant, a pure antiestrogen that competes with the natural estrogens for binding to the estrogen receptors. This Bik induction preceded apoptotic cell death, which was blocked by zVAD-fmk, a pancaspase inhibitor. Amounts of the Bcl-2-related proteins, such as Bcl-2, Bcl-XL, or Bax, showed only marginal changes in the presence or absence of estrogens or antiestrogens. Suppression of Bik expression by using the small interfering RNA effectively blocked the fulvestrant-induced breast cancer cell apoptosis. These results indicate that Bik is induced in MCF-7/BUS cells in the absence of estrogen signaling and plays a critical role in the antiestrogen-provoked breast cancer cell apoptosis.

Indexed as

ApoptosisApoptosis Regulatory ProteinsBase SequenceBreast NeoplasmsCell Line, TumorDNA PrimersEstradiolEstrogen Receptor ModulatorsEstrogensFemaleGene Expression Regulation, NeoplasticHumansKineticsMembrane ProteinsMitochondrial ProteinsRNA, Small InterferingApoptosis Regulatory ProteinsBIK protein, humanDNA PrimersEstradiolEstrogen Receptor ModulatorsEstrogensMembrane ProteinsMitochondrial ProteinsRNA, Small Interfering

Identifiers

PMID14983013
PMCPMC356954
OpenAlexW2024645138

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.